Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muralikrishnan Dhanasekaran

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Current Neurovascular Research|December 27, 2005
The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitusMuralikrishnan Dhanasekaran, Jun Ren
Experimental Neurology|December 7, 2007
Amyloid beta peptides and glutamatergic synaptic dysregulationKodeeswaran Parameshwaran, Muralikrishnan Dhanasekaran, Vishnu Suppiramaniam
Phytotherapy Research : PTR|September 24, 2005
Antioxidant and DNA protecting properties of anti-fatigue herb Trichopus zeylanicusBinu Tharakan, Muralikrishnan Dhanasekaran, Bala V Manyam
Life Sciences|January 4, 2012
Differential effects of dopaminergic neurotoxins on DNA cleavageBinu Tharakan, Muralikrishnan Dhanasekaran, Bala V Manyam
Phytotherapy Research : PTR|December 8, 2007
Antiparkinson drug--Mucuna pruriens shows antioxidant and metal chelating activityMuralikrishnan Dhanasekaran, Binu Tharakan, Bala V Manyam
Life Sciences|May 8, 2016
Evaluating the neurotoxic effects of Deepwater Horizon oil spill residues trapped along Alabama's beachesDwipayan Bhattacharya, T Prabhakar Clement, Muralikrishnan Dhanasekaran
Phytotherapy Research : PTR|October 13, 2004
Neuroprotective effects of the antiparkinson drug Mucuna pruriensBala V Manyam, Muralikrishnan Dhanasekaran, Theodore A Hare
Phytotherapy Research : PTR|March 17, 2004
Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmittersBala V Manyam, Muralikrishnan Dhanasekaran, Theodore A Hare
Pharmacological Research|July 2, 2022
Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapyYiran E Li, Amir Ajoolabady, Muralikrishnan Dhanasekaran, et al.
Pharmacological Reports : PR|January 19, 2010
Methamphetamine-induced neurotoxicity: the road to Parkinson's diseaseBessy Thrash, Kariharan Thiruchelvan, Manuj Ahuja, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Current Neurovascular Research|December 27, 2005
The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitusMuralikrishnan Dhanasekaran, Jun Ren
Experimental Neurology|December 7, 2007
Amyloid beta peptides and glutamatergic synaptic dysregulationKodeeswaran Parameshwaran, Muralikrishnan Dhanasekaran, Vishnu Suppiramaniam
Phytotherapy Research : PTR|September 24, 2005
Antioxidant and DNA protecting properties of anti-fatigue herb Trichopus zeylanicusBinu Tharakan, Muralikrishnan Dhanasekaran, Bala V Manyam
Life Sciences|January 4, 2012
Differential effects of dopaminergic neurotoxins on DNA cleavageBinu Tharakan, Muralikrishnan Dhanasekaran, Bala V Manyam
Phytotherapy Research : PTR|December 8, 2007
Antiparkinson drug--Mucuna pruriens shows antioxidant and metal chelating activityMuralikrishnan Dhanasekaran, Binu Tharakan, Bala V Manyam
Life Sciences|May 8, 2016
Evaluating the neurotoxic effects of Deepwater Horizon oil spill residues trapped along Alabama's beachesDwipayan Bhattacharya, T Prabhakar Clement, Muralikrishnan Dhanasekaran
Phytotherapy Research : PTR|October 13, 2004
Neuroprotective effects of the antiparkinson drug Mucuna pruriensBala V Manyam, Muralikrishnan Dhanasekaran, Theodore A Hare
Phytotherapy Research : PTR|March 17, 2004
Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmittersBala V Manyam, Muralikrishnan Dhanasekaran, Theodore A Hare
Pharmacological Research|July 2, 2022
Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapyYiran E Li, Amir Ajoolabady, Muralikrishnan Dhanasekaran, et al.
Pharmacological Reports : PR|January 19, 2010
Methamphetamine-induced neurotoxicity: the road to Parkinson's diseaseBessy Thrash, Kariharan Thiruchelvan, Manuj Ahuja, et al.
Pageof 12